Pharmacovigilance, the monitoring and assessment of drug safety, is a crucial aspect of healthcare that often involves healthcare professionals but rarely includes active participation from patients. Dr. Rajeev Singh Raghuvanshi, the Drugs Controller General of India (DCGI), emphasized the importance of patients playing a proactive role in pharmacovigilance during the 5th National Pharmacovigilance Week held at the Bharat Mandapam Convention Centre in New Delhi.
This annual event, organized by the Indian Pharmacopoeia Commission (IPC) which serves as the National Coordination Centre for the Pharmacovigilance Programme of India (NCC-PvPI), is observed from September 17-23 under the theme “Your Safety, Just a Click Away: Report to PvPI”. The focus is on raising awareness among healthcare professionals, regulators, researchers, and the general public about the significance of reporting adverse drug reactions (ADRs) through user-friendly digital platforms.
Traditionally, the majority of pharmacovigilance reports have originated from healthcare professionals. However, Dr. Raghuvanshi stressed that for pharmacovigilance efforts to be truly impactful, patients need to actively participate in reporting ADRs. He highlighted India’s commendable contribution to global adverse event reporting but noted that there is still untapped potential in utilizing the wealth of data available for enhancing pharmacovigilance practices.
In his address, Dr. Raghuvanshi called for a shift in the culture surrounding pharmacovigilance, advocating for a more inquisitive approach within organizations rather than a fearful one. He emphasized the importance of integrating technology and innovative strategies to foster a culture of proactive reporting and critical thinking in pharmacovigilance processes.
As part of the event, the IPC introduced several new initiatives aimed at improving pharmacovigilance awareness and accessibility. These included the premiere of a short film on PvPI, the publication of a pharmacovigilance comic in various regional languages to enhance public engagement, and the launch of an online reporting platform accessible through a QR code.
The evolving landscape of pharmacovigilance in India is marked by a stronger foundation and the development of tailored policies and regulations to meet the changing needs of the country. The push for patient involvement in pharmacovigilance is a crucial step towards ensuring comprehensive drug safety monitoring and enhancing public health outcomes.
In conclusion, the active participation of patients in pharmacovigilance is vital for comprehensive drug safety monitoring. By encouraging patients to report adverse drug reactions, India can further strengthen its pharmacovigilance program and contribute significantly to global drug safety efforts.
Key Takeaways:
– Patients play a crucial role in pharmacovigilance by reporting adverse drug reactions.
– India is making strides in adverse event reporting but can benefit from increased patient involvement.
– Integrating technology and fostering a culture of curiosity are essential for enhancing pharmacovigilance practices.
– New initiatives such as regional language pharmacovigilance comics aim to raise public awareness about drug safety.
Read more on thehansindia.com